Cautions & security deposits

Your belongings protected with Booloopay

Securely hold a deposit without debiting the account, collect payments securely, and release funds with a single click. Peace of mind for you, confidence for your clients.



Primary lung cancer

Definition

Definition

Primary lung cancer is a malignant tumor that originates in the mucosa (layer of cells covering hollow organs in contact with the air) lining the bronchi (air passages resulting from the division in two of the trachea, extended by their branches).

About 50% of lung cancer patients have metastases (spread of the cancerous tumor far from its original site).

The 5-year survival rate is approximately 30% in men and 50% in women.

                                                                                                                 

Classification

After a microscopic study of biopsies (samples) of lung cancer cells, two types of cells are distinguished:

  • Le small cell carcinoma.
  • Le Kulchitzky Masson small cell carcinoma (20 to 25% of cases).

These cells originate from the epithelia (a collection of cells forming a lining layer) of the lungs. Three types are distinguished:

  1. Type 1 or typical carcinoid, whose prognosis is good.
  2. Type 2 or carcinoid atypical, whose prognosis is less good.
  3. Type 3 or small cell carcinoma, whose prognosis is the worst of all bronchial tumors, and whose metastases are relatively early. This term small cell carcinoma concerns:
  • Le squamous cell cancer (30 to 35% of cases), with a fairly slow progression, accompanied by late metastases.
  • Adenocarcinoma (30 to 35% of cases), characterized by the destruction of the bronchial wall. It frequently gives rise to metastases and develops mainly on pulmonary scars of fibrous origin.
  • Le bronchioloalveolar cancer (see below).
  • Le sarcoma (malignant tumor that develops at the expense of the connective tissue of the lung), with a poor prognosis. connective tissue is the body's filling and supporting tissue.
  • Le Hodgkin's or non-Hodgkin's lymphoma (often associated with inhalation of air pollutants).

Symptoms

Symptoms

  • Chest pain (which may be due to direct invasion by the cancerous tumor), likely to radiate towards the shoulder and sometimes even towards the abdomen.
  • Cough.
  • Dyspnea (difficulty breathing during or outside of exercise).
  • Weight loss.
  • Sputum (rejection of mucus, mucus) in significant quantities, leading to a hypoxemia also called anoxemia (decrease in the amount of oxygen in the blood).
  • Difficulty expressing sounds (dysphonia).
  • Asthenia (fatigue).
  • Hemoptysis (coughing up blood).
  • hyperthermia (dragging fever).
  • Persistent or recurring lung infection, for which the antibiotics do not give good results.
  • Dysphagia (difficulty swallowing) which may indicate an impairment of the esophagus or one recurrent nerve palsy (damage to the vocal cords resulting in an abnormally pitched voice).
  • Pleurisy : acute or chronic inflammation of the pleura surrounding the lungs, accompanied by a effusion, and D'bleeding, which may cause pain which may be aggravated by the cough and inspiration (phase of breathing during which air enters the lungs). Generally, upon auscultation, the doctor hears a rubbing noise at the same rhythm as breathing.
  • When the cancer is located at one of the two apices of the lungs, we speak of Pancoast Tobias syndrome (also called apical tumor). It is characterized by severe pain in the shoulder and arm, and is sometimes accompanied by the syndrome called Claude Bernard-HornerThis one associates a paralysis of the dilator muscle (which opens) of the pupil, that is to say that when the doctor puts his hand over the eye to hide it from the light, the pupil dilates very slowly, on the other hand, it contracts very quickly as soon as the doctor has removed his hand (that is to say as soon as the light has entered the eye). The second sign of Horner syndrome is the narrowing of the space between the two eyelids. It indicates a paralysis of a muscle used to raise the eyelid. The third sign is what is called a enophthalmos (the eye is positioned deeper in the orbit than normal).
  • ganglions the level of axillary hollow (under the arm), with bone pain.
  • Increased liver volume (hepatomegaly).
  • Brain tumor.
  • Superior vena cava syndrome due to an invasion by cancer cells of the entire region, which can result in obstruction of vessels.
  • Heart rhythm disorders due to insufficient functioning of the heart.
  • Obstruction of lymph vessels preventing the flow of lymph, with effusion at the level of the pulmonary pleura. Of course, the achievement of the bronchioles and alveoli causes at this level a failure of functioning
  • Le paraneoplastic syndrome is a set of signs that sometimes accompanies a malignant tumor without having any direct (anatomical) relationship with it. The syndrome disappears if the cancer in question is treated, and it reappears in the presence of a recurrence of the cancer itself, or of one of its metastases. With regard to bronchopulmonary cancer, the paraneoplastic syndrome takes in particular the following forms:
    • Le Pierre Marie syndrome, which consists of an increase in the volume of the joints of the bones of the hands and feet, associated with lung disease. Usually, it is accompanied by pain, and sometimes by what is called a digital hippocratism, that is to say a hypertrophy (increase in volume) of phalanges and nails (which take the form of a watch glass). The fingers resemble drumsticks. The radio shows a bone demineralization, and hypertrophy can affect the entire hand. It can also affect the wrist, foot and extend to the thorax, clavicles and shoulder blades. Joint pain is also present, accompanied by an increase in volume of the joints but containing a non-inflammatory synovial fluidWhen these deformations reach a significant stage, they lead to major functional importance (great difficulty in movement).
    • Le Schwartz-Bartter syndrome, which occurs mainly in small cell cancers and consists of inappropriate secretion of antidiuretic hormone. It leads to water retention and hyponatremia (decrease in sodium in the blood).

Epidemiology

Primary lung cancer ( which has a poor prognosis) affects approximately 30.000 individuals each year in France.

The peak number of people affected by this pathology is around 60 years old.

Since the anti-smoking campaigns, this number seems to be decreasing slightly.

However, the female sex is more affected than before.

Medical exam

Labo

Tumor markers , such as neuroenolase antigen (NSE) or carcinoembryonic antigen , are not very specific but sometimes guide the diagnosis.

They are mainly used to monitor progress after chemotherapy treatment (a combination of anticancer drugs) or after surgery.

Additional examination

X-ray
It allows a diagnosis to be made with greater certainty. The X-ray of the thorax can detect the presence of ganglia the level of mediastinum , region located between the lungs, which contain:

Bronchial fibroscopy
It allows the lesion to be biopsied and seen. This examination allows a diagnosis in approximately 80% of cases, thanks to the cytological sampling (tumor cells) performed.

Thoracotomy (opening of the chest)
It allows this to be explored when the tests mentioned above have not produced conclusive results. We then speak of exploratory thoracotomy, which is sometimes the only way to make a diagnosis with certainty. This is the case, for example, when lung cancer develops through a single tumor (nodule). In this case, the pbiopsy anointing made with the help of the scanner allows solitary nodules to be located.

MRI

It provides information regarding the location and, more importantly, the extent of the tumor. This examination is particularly useful to the surgeon as a pre-operative assessment.

Bone or liver scan
It allows the search for metastases at the level of the liver or in os

Cause

Cause

Tobacco is the cause of many of these cancers (starting at 10 to 20 cigarettes per day). For 40 cigarettes, the risk is multiplied by 60.

Also involved in the occurrence of primary bronchial cancers:

Anatomical changes in the lungs ( fibrosis among others) are also likely to lead to this pathology.

Treatment

Treatment

Surgical intervention allows for the removal of the tumor, which should be done as early as possible. It is particularly indicated when there is squamous cell carcinoma (whose nature resembles that of the epidermis: the skin) or adenocarcinoma (cancer reproducing glandular tissue).

The combination of complex chemotherapy (vincristine, cyclophosphamide, methotrexate, CCNU) and radiotherapy ( irradiation during cancer treatment) can lead to partial or complete remissions in small cell carcinomas that cannot be operated on.

Evolution

Evolution

After treatment, the survival rate for primary bronchopulmonary cancer can reach around 50% over five years if complete excision (removal) has been possible.

Average survival is only about 15 to 18 months in localized forms, and 10 to 12 months for disseminated forms.

The percentage of patients surviving beyond 2 years is below 20%.